As the founding faculty director of Dana-Farber’s Cancer Care Equity Program, Dr. Lathan leads the program’s efforts to reduce disparities in cancer outcomes for historically marginalized groups in the Greater Boston area and to become a national model for translating cancer equity research into interventions. He aims to bridge the gap between research efforts in disparities and the realities of patient care by increasing access to high-quality care, developed in part through community engagement. Dr. Lathan also leads research centered on the effects of race, class and access to care in cancer outcomes, including racial disparities in lung cancer treatment, differences in access to precision medicine by race and social class, and equitable distribution of new treatment across historically marginalized populations. He is a medical oncologist specializing in lung cancer and is associate medical director of Dana-Farber’s regional campuses.
